Gavi, addressing the surge in cholera outbreaks across Africa, reports progress in vaccine supply. Initially strained, supply is stabilizing with a 30% boost from South Korea’s EuBiologics and plans to engage Indian and African producers. Aurelia Nguyen, Gavi’s chief, links outbreaks to climate change, integrating this factor into vaccine strategies. Gavi emphasizes equitable access, ensuring fair pricing without compromising quality. With projections of 50 million doses in 2024 and up to 65 million in 2025, Gavi aims to fortify global health resilience amid evolving challenges.
Securing Cholera Vaccines Amid African Outbreaks: Gavi’s Efforts
![](https://affairsace-media.s3.ap-south-1.amazonaws.com/2024/06/19091834/ezgif.com-webp-to-jpg-converter-2-3-860x471.jpg)